Health Care & Life Sciences » Pharmaceuticals | Boston Therapeutics Inc.

Boston Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
323.40
199.60
98.90
98.90
29.40
31.70
Cost of Goods Sold (COGS) incl. D&A
278.20
175.80
240.50
94.10
114.00
225.30
Gross Income
45.20
23.80
141.50
4.70
84.70
193.60
SG&A Expense
4,625.50
4,698.10
1,959.80
1,268.70
1,181.00
1,839.80
EBIT
4,580.30
4,674.40
2,101.30
1,264.00
1,265.70
2,033.40
Unusual Expense
-
-
275.30
124.50
1,462.80
760.10
Non Operating Income/Expense
1.60
5.60
4.30
402.00
-
-
Interest Expense
19.70
20.00
659.60
1,943.00
1,782.00
807.70
Pretax Income
4,601.50
4,699.90
2,489.80
3,733.50
1,584.90
3,601.20
Income Tax
-
-
-
4.00
-
-
Consolidated Net Income
4,601.50
4,699.90
2,489.80
3,737.50
1,584.90
3,601.20
Net Income
4,601.50
4,699.90
2,489.80
3,737.50
1,584.90
3,601.20
Net Income After Extraordinaries
4,601.50
4,699.90
2,489.80
3,737.50
1,584.90
3,601.20
Net Income Available to Common
4,601.50
4,699.90
2,489.80
3,737.50
1,584.90
3,601.20
EPS (Basic)
0.18
0.12
0.06
0.09
0.03
0.04
Basic Shares Outstanding
25,370.60
38,192.40
39,113.90
43,535.20
51,467.10
102,498
EPS (Diluted)
0.18
0.12
0.06
0.09
0.03
0.04
Diluted Shares Outstanding
25,370.60
38,192.40
39,113.90
43,535.20
51,467.10
102,498
EBITDA
4,513.20
4,603.40
2,030.30
1,193.60
1,198.70
1,873.50

About Boston Therapeutics

View Profile
Address
354 Merrimack Street No. 4
Lawrence Massachusetts 01843
United States
Employees -
Website http://www.bostonti.com
Updated 07/08/2019
Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products are designed to help manage blood sugar, treat pre-diabetes, and diabetes related pathologies. Its drug candidates comprises of BTI320, BTI-410, and IPOXYN.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.